Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer

BACKGROUND: Prolonged infusion of low dose gemcitabine (PLDG) in combination with platinum has shown promising activity in terms of improved response rate and progression free survival (PFS); especially in squamous non-small cell lung cancer (NSCLC). Hence, we conducted a phase 3 randomized non-infe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:EClinicalMedicine
Autori principali: Patil, Vijay, Noronha, Vanita, Joshi, Amit, Chougule, Anuradha, Kannan, Sadhana, Bhattacharjee, Atanu, Goud, Supriya, More, Sucheta, Chandrasekharan, Arun, Menon, Nandini, Srinivas, Sujay, Vallathol, Dilip Harindran, Dsouza, Hollis, Majumdar, Swaratika, Das, Sudeep, Zawar, Abhinav, Khaddar, Satvik, Kumar, Amit, Singh, Gunjesh, Kumar, Kanteti Aditya Pavan, Ravind, Rahul, Trivedi, Vaishakhi, Behel, Vichitra, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510888/
https://ncbi.nlm.nih.gov/pubmed/31143878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.03.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi